# Bristol-Myers Squibb Company (BMY) — Q2-2019 Earnings Results

**Report date:** 2019-07-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2019

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 5.02%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.18 | N/A | +8.87% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to pipeline advancements. They emphasized the importance of continuing to deliver value to patients.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on advancing our pipeline and delivering value to patients.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's strong EPS performance exceeded expectations, which contributed to a positive stock reaction, with shares rising by 5.02%. The company did not provide any updates on future guidance, leaving investors to focus on the current results and the ongoing development of its product pipeline. This quarter's performance may bolster investor confidence as the company continues to navigate the competitive landscape in the pharmaceutical industry.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2019_